NeuroSearch Sweden AB: Next Steps to Treat Parkinson's, Huntington's and Alzheimer's Disease.
He discussed compound ACR16 or pridopidine, which is a generic name, that was developed in Carlsson Research about ten years ago. It belongs to a new class of compounds called dopidines which are developed from an in vivo screening method.
Carlsson Research started with the hypothesis that there is no target but rather you have to change the way the brain works, the system, the connectivity of the various brain areas associated with Huntingdon's disease.
''What we've found out is these compounds that can modulate dopamine transmission but also strengthen glutamartology ...






